Rational therapy for vaginal infections is a gynecologist’s choice
M.S. Selikhova, T.I. Kostenko, A.A. Smol’yaninov
Volgograd State Medical University, Volgograd, Russian Federation
Vaginal discharge is the most common reason for referral to a gynecologist. Given the polyetiological nature of vaginal infections, broad-spectrum medications are selected for treatment. Antiseptic solutions (whose efficacy is similar to antibiotics) included in Russian clinical guidelines for obstetrics and gynecology are now more favored. Chlorohexidine is the most studied antiseptic solution with established efficacy in obstetrics and gynecology, whose hallmark is the lack of inhibiting effects on Lactobacilli and local immunity. Combining chlorohexidine and dexpanthenol is one of the most promising therapeutic tools for bacterial vaginosis and vaginal infections. Dexpanthenol stimulates reparation and recovering vaginal and cervical mucosal integrity. This property is crucial for reducing inflammation and preventing recurrences. Recent multicenter randomized and observational study results have demonstrated high efficacy, safety, and good tolerability of combined preparation for vulvovaginitis of different etiologies and vaginal dysbiosis in women of reproductive age, postmenopausal and pregnant women, and while breastfeeding.
Keywords: vaginal dysbiosis, vulvovaginitis, antiseptic, broad-spectrum, Lactobacilli, reparative.
For citation: Selikhova M.S., Kostenko T.I., Smol’yaninov A.A. Rational therapy for vaginal infections is a gynecologist’s choice. Russian Journal of Woman and Child Health. 2022;5(1):41–45 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-41-45.
Acknowledgements
The technical edition is supported by STADA AG.
About the authors:
Marina S. Selikhova — Dr. Sc. (Med.), Professor, professor of the Department of Obstetrics and Gynecology, Volgograd State Medical University; 1, Pavshikh Bortsov sq., Volgograd, 400131, Russian Federation; ORCID ID 0000-0002-4393-6111.
Tatyana I. Kostenko — C. Sc. (Med.), Associate Professor, associate professor of the Department of Obstetrics and Gynecology, Volgograd State Medical University; 1, Pavshikh Bortsov sq., Volgograd, 400131, Russian Federation; ORCID ID 0000-0001-5203-3400.
Aleksandr A. Smol’yaninov — postgraduate student of the Department of Obstetrics and Gynecology, Volgograd State Medical University; 1, Pavshikh Bortsov sq., Volgograd, 400131, Russian Federation; ORCID ID 0000-0002-4113-0771.
Contact information: Marina S. Selikhova, e-mail: selichovamarina@yandex.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 05.11.2021.
Revised 30.11.2021.
Accepted 23.12.2021.
2. Paladine H.L., Desai U.A. Vaginitis: diagnosis and treatment. Am Fam Physician. 2018;97(5):321–329.
3. Savicheva A.M., Spasibova E.V., Shalepo K.V. Investigation of the susceptibility of clinical microbial isolates from the female urogenital tract to the active ingredients contained in Depanthol. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(1):86–91 (in Russ.). DOI: 10.17116/rosakush20191901192.
4. Nazarova N.M., Nekrasova M.E., Dovletkhanova E.R., Abakarova P.R. Vaginitis and cervicitis: choice of an effective therapy method (literature review). Meditsinskiy sovet. 2020;3:17–23 (in Russ.). DOI: 10.21518/2079-701X-2020-3-17-23.
5. Radzinskiy V.E., Petrov Yu.A., Kalinina E.A. et al. Pathogenetic features of the macrotypes of chronic endometritis. Kazanskiy meditsinskiy zhurnal. 2017;98(1):27–34 (in Russ.). DOI: 10.17750/KMJ2017-27.
6. Mikhaylin E.S., Ivanova L.A., Savitsky A.G., Berlev I.V. Features of reproductive health of modern adolescent girls (analytical review). Reproduktivnoye zdorov’ye detey i podrostkov. 2015;2:63–72 (in Russ.).
7. Putintseva O.G., Verevkina E.V. Inflammatory diseases of the pelvic organs: a study guide. Blagoveshchensk; 2017 (in Russ.).
8. Selikhova M.S., Soltys P.A., Smolyaninov A.A. Treatment and prevention of recurrent vulvovaginal infections in patients with pelvic inflammatory disease. Gynecology, obstetrics and perinatology. 2021;20(2):58–65 (in Russ.). DOI: 10.20953/1726-1678-2021-2-58-64.
9. Sherrard J., Wilson J., Donders G. et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258–1272. DOI: 10.1177/0956462418785451.
10. Palacios S., Nappi R.N., Bruyniks N. et al. The European vulvovaginal epidemiological survey: prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric. 2018;21(3):286–291. DOI: 10.1080/13697137.2018.1446930.
11. Douders G.G., Ruban K., Bellen G. Selecting anti-microbial treatment of aerobic vaginitis. Curr Infect Dis Rep. 2015;17(5):477. DOI: 10.1007/s11908-015-0477-6.
12. Van Schalkwyk J., Yudin MH; INFECTIOUS DISEASE COMMITTEE. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can. 2015;37(3):266-274. doi: 10.1016/S1701-2163(15)30316-9.
13. Budanov P.V., Musayev Z.M., Aslanov A.G. Modern principles of therapy of bacterial vaginosis. Gynecology, obstetrics and perinatology. 2012;11(2):58–62 (in Russ.).
14. Dobrokhotova Yu.E., Bondarenko K.R., Shadrova P.A. The role of lactobacilli in restoring normal vaginal microbiota. Gynecology, obstetrics and perinatology. 2021:20(2):126–134 (in Russ.). DOI: 10.20953/1726-1678-2021-2-126-132.
15. Clinical recommendations of the Ministry of Health of the Russian Federation. Inflammatory diseases of the female pelvic organs. 2021 (in Russ.).
16. Osipchuk D.O., Zhilin A.V., Pastukhova T.P., Boronina L.G. Optimal use of antimicrobial agents in obstetric practice. Doctor.Ru. 2016;7(124):45–51 (in Russ.).
17. Karapetyan T.E., Tyutyunnik V.L., Mikhaylova O.I., Medzhidova M.K. Modern ideas and basic principles of treatment of nonspecific vaginitis. Russian Journal of Woman and Child Health. 2012;1:24.
18. Selikhova M.S., Smolyaninov A.A. New opportunities in treatment of vaginal infections. Obstetrics and gynecology. News. Views. Education. 2019;7(1(23)):75–78 (in Russ.).
19. ROАG. Clinical guidelines for the diagnosis and treatment of diseases accompanied by pathological discharge from the genital tract of women. 2019 (in Russ.).
20. Kuz’min V.N. Antibiotic resistance in obstetrics and gynecology as an epidemiological problem of our time. Lechaschi vrach. 2017;12:17–22 (in Russ.).
21. Lisicyna O.I., Khilkevich E.G. Antibiotic resistance — a modern global health problem, the search for possible solutions in treatment PID. Medical council. 2018;13:136–140 (in Russ.). DOI: 10.21518/2079-701X-2018-13-136-140.
22. Apolikhina I.A., Efendiyeva Z.N. Current trends in the treatment of bacterial vaginosis. Obstetrics and gynecology. 2019;12:193–196 (in Russ.). DOI: 10.18565/aig.2019.12.193-196.
23. Workwski K.A., Bolan G.A. Center for Disease Contral and Prevention. Sexually transmitted deseases treatment guidelines, 2015. MMWR Recomm Rep. 2015,64(RR-03):1–137. PMID: 26042815.
24. Kasikhina E.I. Chlorhexidine: a review of treatment options and potential clinical indications in the practice of an obstetrician-gynecologist and a venereologist. Obstetrics and gynecology. 2013;4:4–9 (in Russ.).
26. Rakhmatulina M.R., Plakhova K.I. Bacterial vaginosis associated with Atopobium vaginae. Modern principles of diagnostics and therapy. Obstetrics and gynecology. 2012;3:88–92 (in Russ.).
27. Kira Ye.F., Gamirova Ye.V., Gaytukiyeva R.A., Belyakina I.V. Results of a randomized study of the efficacy and safety of chlorhexidine and metronidazole in the treatment of bacterial vaginosis. Obstetrics and gynecology. 2010;6:8–14 (in Russ.).
28. Savicheva A.M., Spasibova E.V., Shalepo K.V. Investigation of the sensitivity of Streptococcus agalactiae, isolated from the urogenital tract, to the active substances included in the composition of Depantol. 2017;6:96–100 (in Russ.). DOI: 10.17116/rosakush201717696-100.
29. Radzinskiy V.E., Khamoshina M.B., Orazov M.R. et al. Results of a multicenter observational study: therapy of acute non-specific and mixed vaginitis in reproductive-aged patients. Obstetrics and Gynecology. 2019;8:150–159 (in Russ.). DOI: 10.18565/aig.2019.8.150-158.
30. Oboskalova T.A., Kononova I.N., Voroshilina E.S., Kuzina T.V. Efficiency of rehabilitation measures after destructive therapies in patients with uterine cervical pathology associated with papillomavirus infection. Obstetrics and gynecology. 2012;2:86–89 (in Russ.).
31. Rogovskaya S.I., Terebneva L.A., Podzolkova N.M. Complex therapy of diseases of the cervix with the use of drugs Depantol and Lavomax. Obstetrics and gynecology. 2014;10:95–103 (in Russ.).
32. Kira Ye.F. Bacterial vaginosis. M.: MIA; 2012 (in Russ.).
33. Yefimov B.A., Tyutyunnik V.L. Bacterial vaginosis: a modern view of the problem. RMJ. 2008;16(1):18–22 (in Russ.).
34. Depantol. Instructions for the medical use of the medicinal product. (Electronic resource.) URL: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=06b06e72-e81e-4d0d-8d0c-db86478cb5f9&t= (access date: 01.11.2021) (in Russ.).
35. Selikhova M.S., Ababekyan N.V. Optimal treatment of bacterial vaginosis before delivery. Doctor.Ru. 2020;19(6):36–39 (in Russ.). DOI: 10.31550/1727-2378-2020-19-6-30-35.
36. Selikhova M.S., Vdovin S.V., Kotovskaya M.V., Ababekyan N.V. Modern approaches to the management of puerperas with birth injuries. Obstetrics and gynecology. 2013;5:70–75 (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
